You are on page 1of 2

Accessed from 186.77.229.

70 by ebsc0sa on Fri Dec 06 21:29:06 EST 2013


144 á197ñ Spectrophotometric Identification Tests / Chemical Tests USP 37

á197ñ SPECTROPHOTOMETRIC Differences that may be observed in the spectra so ob-


tained sometimes are attributed to the presence of poly-
IDENTIFICATION TESTS morphs, which are not always acceptable (see Procedure un-
der Spectrophotometry and Light-Scattering á851ñ). Unless
otherwise directed in the individual monograph, therefore,
Spectrophotometric tests contribute meaningfully toward continue as follows. If a difference appears in the IR spectra
the identification of many compendial chemical substances. of the analyte and the standard, dissolve equal portions of
The test procedures that follow are applicable to substances the test specimen and the Reference Standard in equal vol-
that absorb IR and/or UV radiation (see Spectrophotometry umes of a suitable solvent, evaporate the solution to dryness
and Light-Scattering á851ñ). in similar containers under identical conditions, and repeat
The IR absorption spectrum of a substance, compared the test on the residues.
with that obtained concomitantly for the corresponding
USP Reference Standard, provides perhaps the most conclu- ULTRAVIOLET ABSORPTION
sive evidence of the identity of the substance that can be re-
alized from any single test. The UV absorption spectrum, on The reference á197Uñ in a monograph signifies that a test
the other hand, does not exhibit a high degree of specifici- solution and a Standard solution are examined spectropho-
ty. Conformance with both IR absorption and UV absorption tometrically, in 1-cm cells, over the spectral range from 200
test specifications, as called for in a large proportion of com- to 400 nm unless otherwise specified in the individual mon-
pendial monographs, leaves little doubt, if any, regarding ograph.
the identity of the specimen under examination. Dissolve a portion of the substance under examination in
General Chapters

the designated Medium to obtain a test solution having the


INFRARED ABSORPTION concentration specified in the monograph for Solution. Simi-
larly prepare a Standard solution containing the correspond-
Seven methods are indicated for the preparation of previ- ing USP Reference Standard.
ously dried test specimens and Reference Standards for anal- Record and compare the spectra concomitantly obtained
ysis. The reference á197Kñ in a monograph signifies that the for the test solution and the Standard solution. Calculate ab-
substance under examination is mixed intimately with po- sorptivities and/or absorbance ratios where these criteria are
tassium bromide. The reference á197Mñ in a monograph included in an individual monograph. Unless otherwise
signifies that the substance under examination is finely specified, absorbances indicated for these calculations are
ground and dispersed in mineral oil. The reference á197Fñ in those measured at the maximum absorbance at about the
a monograph signifies that the substance under examina- wavelength specified in the individual monograph. Where
tion is suspended neat between suitable (for example, so- the absorbance is to be measured at about the specified
dium chloride or potassium bromide) plates. The reference wavelength other than that of maximum absorbance, the
á197Sñ signifies that a solution of designated concentration abbreviations (min) and (sh) are used to indicate a mini-
is prepared in the solvent specified in the individual mono- mum and shoulder, respectively, in an absorption spectrum.
graph, and the solution is examined in 0.1-mm cells unless a The requirements are met if the UV absorption spectra of
different cell path length is specified in the individual mono- the test solution and the Standard solution exhibit maxima
graph. The reference á197Añ signifies that the substance un- and minima at the same wavelengths and absorptivities
der examination is intimately in contact with an internal re- and/or absorbance ratios are within specified limits.
flection element for attenuated total reflectance (ATR) analy-
sis. The reference á197Eñ signifies that the substance under
examination is pressed as a thin sample against a suitable
plate for IR microscopic analysis. The reference á197Dñ in a á201ñ THIN-LAYER
monograph signifies that the substance under examination
is mixed intimately with an IR-transparent material and CHROMATOGRAPHIC
transferred to a sample container for diffuse reflection (DR) IDENTIFICATION TEST
analysis. The ATR á197Añ and the á197Eñ techniques can be
used as alternative methods for á197Kñ, á197Mñ, á197Fñ, and
á197Sñ where testing is performed qualitatively and the Ref-
GENERAL PROCEDURE
erence Standard spectra are similarly obtained.
Record the spectra of the test specimen and the corre-
The following procedure is applicable as an aid in verify-
sponding USP Reference Standard over the range from
ing the identities of many compendial drug substances as
about 2.6 mm to 15 mm (3800 cm–1 to 650 cm–1) unless oth-
such and in their respective dosage forms.
erwise specified in the individual monograph. The IR absorp-
Prepare a test solution as directed in the individual mono-
tion spectrum of the preparation of the test specimen, previ-
graph. On a line parallel to and about 2 cm from the edge
ously dried under conditions specified for the corresponding
of a suitable thin-layer chromatographic plate, coated with a
Reference Standard unless otherwise specified, or unless the
0.25-mm layer of chromatographic silica gel mixture (see
Reference Standard is to be used without drying, exhibits
Chromatography á621ñ) apply 10 mL of this solution and 10
maxima only at the same wavelengths as that of a similar
mL of a Standard solution prepared from the USP Reference
preparation of the corresponding USP Reference Standard.
Standard for the drug substance being identified, in the

Official from May 1, 2014


Copyright (c) 2013 The United States Pharmacopeial Convention. All rights reserved.
Accessed from 186.77.229.70 by ebsc0sa on Fri Dec 06 21:29:06 EST 2013
USP 37 Chemical Tests / á206ñ Aluminum 145

same solvent and at the same concentration as the test solu- obtain a solution containing 10,000 USP Polymyxin B Units
tion, unless otherwise directed in the individual monograph. per mL. Where the article under test also contains Bacitracin
Allow the spots to dry, and develop the chromatogram in a or Bacitracin Zinc, dissolve a portion of USP Polymyxin B
solvent system consisting of a mixture of chloroform, meth- Sulfate RS in 0.1 N hydrochloric acid to obtain a solution
anol, and water (180:15:1), unless otherwise directed in the containing 500J USP Polymyxin B Units per mL, J being the
individual monograph, until the solvent front has moved ratio of the labeled amount of USP Polymyxin B Units to the
about three-fourths of the length of the plate. Remove the labeled amount of USP Bacitracin Units in each g of Cream,
plate from the developing chamber, mark the solvent front, Lotion, or Ointment.
and allow the solvent to evaporate. Unless otherwise direc- Developing Solvent Solution—Prepare a mixture of
ted in the individual monograph, locate the spots on the methanol, isopropyl alcohol, methylene chloride, ammoni-
plate by examination under short-wavelength UV light. The um hydroxide, and water (4:2:2:2:1.5).
RF value of the principal spot obtained from the test solution Procedure—Apply 10 mL of the Test Solution and each of
corresponds to that obtained from the Standard solution. the relevant Standard Solutions to a suitable thin-layer chro-
matographic plate (see Chromatography á621ñ) coated with
PROCEDURE FOR BACITRACIN, NEOMYCIN, a 0.25-mm layer of chromatographic silica gel. Place the
AND POLYMYXIN B plate in a presaturated chromatographic chamber, and de-
velop the chromatogram with the Developing Solvent System
The following thin-layer chromatographic procedure is until the solvent front has moved about three-fourths of the
applicable as an aid in verifying the identities of bacitracin, length of the plate. Remove the plate from the chamber,
neomycin, and polymyxin B active ingredients and in dos- and dry at 105° for 10 minutes. Spray the plate with a 0.2%

General Chapters
age forms when present singly and in two- and three-com- solution of ninhydrin in butyl alcohol, and heat at 105° for 5
ponent mixtures. The reference á201BNPñ in a monograph minutes. The RF value of each principal spot in the chroma-
signifies that this procedure is intended. togram of the Test Solution corresponds to that of the princi-
Prepare a Test Solution as follows, unless otherwise direc- pal spot in the chromatogram obtained from each relevant
ted in the individual monograph. Standard Solution as appropriate for the labeled active ingre-
Test Solution— dient or ingredients specified on the label. If the chromato-
FOR DRUG SUBSTANCES—Dissolve a portion of Bacitracin, gram of the Test Solution yields excessive streaking, proceed
Bacitracin Zinc, Neomycin Sulfate, or Polymyxin B Sulfate in as directed for Modified Procedure.
0.1 N hydrochloric acid to obtain a solution containing Modified Procedure—Transfer the Test Solution to a 15-
about 500 USP Bacitracin Units per mL, 3.5 mg of neomycin mL centrifuge tube, add 10 mL of saturated aqueous picric
(base) per mL, or 10,000 USP Polymyxin B Units per mL. acid solution (1.2%, w/v), vortex for 1 minute, centrifuge
FOR SOLUTIONS—Where the Solution contains neomycin for 10 minutes, and discard the supernatant. Wash the resi-
and polymyxin B, dilute a portion of it with 0.1 N hydro- due with 1-mL portions of water until no yellow color is ob-
chloric acid to obtain a solution containing the equivalent of served in the washing. Discard the washings, and dry the
about 3.5 mg of neomycin (base) per mL. Where the Solu- residue under a stream of nitrogen at 50°. Dissolve the resi-
tion contains polymyxin B but not neomycin, dilute a por- due in 1 mL of acetone, add 1 mL of a freshly prepared solu-
tion of it with 0.1 N hydrochloric acid to obtain a solution tion of sulfuric acid in acetone (1 in 100), shake, centrifuge
containing about 10,000 USP Polymyxin B Units per mL. for 5 minutes, and discard the supernatant. Rinse the resi-
FOR CREAMS, LOTIONS, AND OINTMENTS—Where the Cream, due with 1 mL of acetone, centrifuge briefly, and discard
Lotion, or Ointment contains Bacitracin or Bacitracin Zinc, the washing. Repeat the washing until no yellow color is ob-
transfer a portion of it equivalent to about 500 USP Bacitra- served. Dry the residue under a stream of nitrogen at 50°.
cin Units, to a 15-mL centrifuge tube. Where the Cream, Lo- Dissolve the residue in 0.5 mL of 0.1 N hydrochloric acid
tion, or Ointment contains neomycin, but not Bacitracin or (Modified Test Solution). Repeat the Procedure using this
Bacitracin Zinc, transfer a portion of it equivalent to about Modified Test Solution instead of the Test Solution. The RF val-
3.5 mg of neomycin (base) per mL to a 15-mL centrifuge ue of each principal spot in the chromatogram of the Modi-
tube. Add 4 mL of chloroform to the centrifuge tube, and fied Test Solution corresponds to that of the principal spot in
shake well to disperse the Cream, Lotion, or Ointment. Add the chromatogram obtained from each relevant Standard
1 mL of 0.1 N hydrochloric acid, vortex for 4 minutes, cen- Solution as appropriate for the active ingredient or ingredi-
trifuge, and use the clear supernatant. ents specified on the label.
NOTE—The Modified Test Solution as described below in
the Modified Procedure may be used in lieu of the Test Solu-
tion. LIMIT TESTS
Standard Bacitracin Solution—Dissolve a portion of USP
Bacitracin Zinc RS in 0.1 N hydrochloric acid to obtain a sol-
ution containing 500 USP Bacitracin Units per mL.
Standard Neomycin Solution—Dissolve a portion of
USP Neomycin Sulfate RS in 0.1 N hydrochloric acid to ob- á206ñ ALUMINUM
tain a solution containing the equivalent of 3.5 mg of neo-
mycin (base) per mL.
Standard Polymyxin B Solution—Dissolve a portion of This procedure is provided to demonstrate that the con-
USP Polymyxin B Sulfate RS in 0.1 N hydrochloric acid to tent of aluminum (Al) does not exceed the limit given in the

Official from May 1, 2014


Copyright (c) 2013 The United States Pharmacopeial Convention. All rights reserved.

You might also like